sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Ocular Drug Delivery Market...

2028年までの欧州眼科ドラッグデリバリー市場予測 - 技術別（植込み型眼科ドラッグデリバリーシステム、微粒子ドラッグデリバリーシステム、ナノ粒子ドラッグデリバリーシステムなど）、製剤タイプ（リポソームおよびナノ粒子、溶液、乳剤、懸濁液、軟膏）、疾患の種類（緑内障、糖尿病性網膜症、ドライアイ症候群、黄斑変性症、白内障、糖尿病性黄斑浮腫など）、エンドユーザー（病院、眼科クリニック、外来手術センター）

TIPRE00025762 | Pages: 152 | Pharmaceuticals | Nov 2021 | Type: Regional | Status: Published

市場紹介

欧州の眼科用ドラッグデリバリー市場は、ドイツ、英国、フランス、イタリア、スペイン、その他のヨーロッパ諸国に分割されています。そしてドイツが市場で最大のシェアを占めた。ドイツの高齢者人口が大幅に増加していることは、国内での眼科ドラッグデリバリー市場の導入拡大にとって有利な機会となっている。 Aging Readiness & によると、競争力イニシアチブによれば、ドイツの 65 歳以上の人口は 2050 年までに 41% 増加して 2,400 万人となり、総人口のほぼ 3 分の 1 を占めると予測されています。また、眼疾患を抱えた患者の数が多いことも市場の成長を促進しています。欧州視覚研究所 EEIG によると、ドイツでは約 30,000 人が遺伝性網膜疾患に罹患しています。デジタル化の進展と小型モバイル機器の広範な使用により、若年層の視力障害が生じ、コンタクトレンズの販売を支えています。さらに、この国は医療機器に対する技術的な支援をしっかりと行っています。この国には、高度な医療機器の開発に専念する企業がいくつかあります。さらに、国内に市場関係者が存在することで、市場での製品の認知度や製品のリーチが高まる可能性があります。 Novaliq はドイツの眼科用製薬会社で、眼科への薬物送達のための初の水を使わない技術を開発しています。 Novaliq は、ドライアイ疾患の治療に使用する技術の開発に重点を置いています。同社の製品は、局所眼科薬物送達用の独自の無水技術 EyeSol を中心としています。

欧州地域は新型コロナウイルス感染症の蔓延によって大規模な打撃を受けており、ほとんどの国がロックダウン状態にあります。定期的な医療サービスは中止され、患者には新型コロナウイルス感染のリスクを最小限に抑えるために病院への来院を避けることが推奨され、医療サービスと患者ケアの提供に大きな混乱が生じた。眼科は最も多忙で外来患者の多い専門分野の 1 つであり、英国では毎年約 750 万件の外来予約があり、50 万件を超える外科手術が行われています。ロックダウンの結果、何千件もの眼科受診や手術がキャンセルされた。これは、患者の視力に永続的かつ重大な損傷を与える可能性があります。さらに、最近の調査によれば、 「英国で眼疾患を抱えて暮らす人々に対する新型コロナウイルス感染症パンデミックのロックダウンの心理社会的影響」この調査は、眼疾患を持つ一般の人々を対象に実施されたもので、ロックダウンが視覚障害のある患者に与える重大な心理社会的悪影響を浮き彫りにしており、患者の約 50% が検査や治療の遅れによる失明の恐怖を表明しています。

市場の概要とダイナミクス

ヨーロッパの眼科用薬物送達市場は、2021 年の 49 億 6,764 万米ドルから 2028 年までに 79 億 2,115 万米ドルに成長すると予想されています。この市場は、2021 年から 2028 年にかけて 6.9% の CAGR で成長すると推定されています。白内障、緑内障、加齢黄斑変性、糖尿病性網膜症、未対処の屈折異常は、失明や視力低下の主な原因の 1 つです。人口のほとんどは、生涯に何らかの眼疾患を患っている、または患っていました。 2021 年 2 月に発表された世界保健機関 (WHO) の報告書「失明と視覚障害」によると、世界中で約 22 億人が近方または遠方の視覚障害を抱えています。また、視力喪失または弱視の主な原因は白内障（9,400万人）と未矯正の屈折異常（8,840万人）であると推定されています。さらに、他の一般的な視力喪失の原因は、緑内障 (770 万人)、角膜混濁 (420 万人)、糖尿病網膜症 (390 万人)、トラコーマ (200 万人) です。 2017 年の王立国立盲人研究所によると、英国では約 35 万人が盲目および弱視者として登録されています。約173,735人が重度視覚障害者として登録されている。 176,125 人が視覚障害者として登録されています。したがって、眼疾患の有病率の増加が眼科用医薬品デリバリー市場を牽引しています。

主要市場セグメント

ヨーロッパの眼科用医薬品デリバリー市場は、テクノロジー、製剤の種類、疾患の種類、エンドユーザーに基づいてセグメント化されています。テクノロジーに基づいて、植込み型眼科ドラッグデリバリーシステムセグメントが2021年に最高のシェアを占めました。製剤タイプに基づいて、ソリューションセグメントが2021年に最高のシェアを占めました。疾患タイプに基づいて、白内障セグメントが2021年に最高のシェアを占めました。 2021 年は、エンド ユーザー病院セグメントが最も高いシェアを占めました。

主要な情報源と企業がリストされています

いくつかの主要な主要および企業ヨーロッパの眼科ドラッグデリバリー市場に関するこのレポートを作成するために参照された二次情報源は、特に企業のウェブサイト、年次報告書、財務報告書、政府文書、統計データベースなどです。レポートに掲載されている主な企業：AbbVie Inc.バウシュ・ヘルス・カンパニーズ社;ノバルティスAG;クリアサイドバイオメディカル株式会社;エンビシア・セラピューティクス。 GRAYBUG VISION, INCとりわけ

購入理由レポート

  • ヨーロッパの眼科用ドラッグデリバリー市場の成長、規模、主要企業、セグメントを特定することで、エントリーレベルの調査にかかる時間を節約、削減します
  • ハイライトキー企業がビジネス戦略を再調整するのを支援するためのビジネス優先事項
  • 主な調査結果と推奨事項は、ヨーロッパの眼科ドラッグデリバリー市場における重要な進歩的な業界トレンドを浮き彫りにし、それによってバリューチェーン全体のプレーヤーが効果的な長期戦略を開発できるようにします。
  • 大幅な成長サービスを提供する先進国および新興市場を利用して、事業拡大計画を策定/変更する
  • 眼科ドラッグデリバリー市場を推進する要因と併せて、ヨーロッパ市場の動向と見通しを徹底的に精査する
  • クライアントの製品、セグメンテーション、価格設定、流通に関する商業的利益を支える戦略を理解することで、意思決定プロセスを強化する

ヨーロッパの眼科用薬物送達市場のセグメンテーション

 

欧州眼科ドラッグデリバリー市場 –テクノロジー別

  • 植込み型眼科薬物送達システム
  • 粒子薬物送達システム
  • ナノ粒子ドラッグデリバリーシステム
  • その他

<スパン>欧州眼科ドラッグデリバリー市場–製剤タイプ別

  • 溶液
  • 軟膏
  • 懸濁液
  • エマルジョン
  • リポソームおよびナノ粒子
< p>欧州眼科薬物送達市場 –病気の種類別

  • 白内障
  • ドライアイ症候群
  • 黄斑変性症
  • 緑内障
  • 糖尿病網膜症
  • 糖尿病性黄斑浮腫
  • その他

ヨーロッパ > 眼科用薬物送達市場 –エンド ユーザー別

  • 病院
  • 眼科クリニック
  • 外来手術センター

ヨーロッパの眼科薬物送達市場 –国別

  • ドイツ
  • フランス
  • イギリス
  • イタリア
  • スペイン
  • 残りヨーロッパの

ヨーロッパの眼科薬物送達市場 –言及されている企業

  • AbbVie Inc.                                                
  • Bausch Health Companies Inc.    ;         
  • ノバルティス AG                   ;                       &nバスプ; 
  • Clearside Biomedical, Inc                 ;     
  • Alimera Sciences, Inc.                 ;           
  • GRAYBUG VISION, INC

TABLE OF CONTENTS

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Europe Ocular Drug Delivery Market – By Technology

1.3.2        Europe Ocular Drug Delivery Market – By Formulation Type

1.3.3        Europe Ocular Drug Delivery Market – By Disease Type

1.3.4        Europe Ocular Drug Delivery Market – By End User

1.3.5        Europe Ocular Drug Delivery Market – By Country

2.          Europe Ocular Drug Delivery Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Europe Ocular Drug Delivery Market – Market Landscape

4.1        Overview

4.2        Expert Opinions

5.          Europe Ocular Drug Delivery Market– Key Market Dynamics

5.1        Market Drivers

5.1.1        Surging Prevalence of Eye Disorders

5.2        Market Restraints

5.2.1        Drawbacks Associated with Ocular Drug Delivery

5.3        Market Opportunities

5.3.1        Raising Awareness About Vision Care

5.4        Future Trends

5.4.1        Emergence of Innovative Products

5.5        Impact analysis

6.          Europe Ocular Drug Delivery – Market Analysis

6.1        Europe Ocular Drug Delivery Market Revenue Forecast and Analysis

7.          Europe Ocular Drug Delivery Market Analysis – By Technology

7.1        Overview

7.2        Europe Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3        Implantable Ocular Drug Delivery Systems

7.3.1        Overview

7.3.2        Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4        Particulate Drug Delivery Systems

7.4.1        Overview

7.4.2        Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5        Nano-Particle Drug Delivery System

7.5.1        Overview

7.5.2        Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6        Others

7.6.1        Overview

7.6.2        Others Market Revenue and Forecast to 2028 (US$ Million)

8.          Europe Ocular Drug Delivery Market Analysis – By Formulation Type

8.1        Overview

8.1.1        Europe Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2        Liposomes and Nanoparticles Market

8.2.1        Overview

8.2.2        Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3        Solution

8.3.1        Overview

8.3.2        Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4        Emulsion

8.4.1        Overview

8.4.2        Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5        Suspension

8.5.1        Overview

8.5.2        Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6        Ointment

8.6.1        Overview

8.6.2        Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9.          Europe Ocular Drug Delivery Market Analysis – By Disease Type

9.1        Overview

9.2        Europe Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3        Cataract

9.3.1        Overview

9.3.2        Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4        Dry Eye Syndrome

9.4.1        Overview

9.4.2        Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5        Macular Degeneration

9.5.1        Overview

9.5.2        Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6        Glaucoma

9.6.1        Overview

9.6.2        Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7        Diabetic Retinopathy

9.7.1        Overview

9.7.2        Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8        Diabetic Macular Edema

9.8.1        Overview

9.8.2        Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9        Others

9.9.1        Overview

9.9.2        Others Market Revenue and Forecast to 2028 (US$ Million)

10.       Europe Ocular Drug Delivery Market Analysis – By End User

10.1      Overview

10.2      Europe Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4      Ophthalmic Clinics

10.4.1     Overview

10.4.2     Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5      Ambulatory Surgical Centers

10.5.1     Overview

10.5.2     Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11.       Europe Ocular Drug Delivery Market – Country Analysis

11.1      Overview

11.1.1     Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)

11.1.1.1       Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.1       Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.2       Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.1.3       Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.1.4       Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.1.5       Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.2       UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.1       UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.2       UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.2.3       UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.2.4       UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.2.5       UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.3       France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1       France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.2       France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.3.3       France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.3.4       France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.3.5       France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.4       Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1       Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.2       Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.4.3       Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.4.4       Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.4.5       Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.5       Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.1       Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.2       Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.5.3       Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.5.4       Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.5.5       Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.6       Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.6.1       Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.6.2       Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.6.3       Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.6.4       Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.6.5       Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

12.       Impact Of COVID-19 Pandemic on Europe Ocular Drug Delivery Market

12.1      Impact Assessment of COVID-19 Pandemic

13.       Industry Landscape

13.1      Overview

13.2      Organic Developments

13.2.1     Overview

13.3      Inorganic Developments

13.3.1     Overview

14.       Company Profiles

14.1      AbbVie Inc.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bausch Health Companies Inc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      GRAYBUG VISION, INC.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Alimera Sciences, Inc.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Novartis AG

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Clearside Biomedical, Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

15.       Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.            Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Million)

Table 2.            Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million).

Table 3.            Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million).

Table 4.            Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Million)

Table 5.            UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Million)

Table 6.            UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million).

Table 7.            UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million).

Table 8.            UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Million)

Table 9.            France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 10.          France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 11.          France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 12.          France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 13.          Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 14.          Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 15.          Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 16.          Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 17.          Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 18.          Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 19.          Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 20.          Spain Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 by End User (USD Million)

Table 21.          Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 22.          Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 23.          Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 24.          Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic Developments Done by Companies

Table 27.          Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1.           Europe Ocular Drug Delivery Market Segmentation

Figure 2.           Europe Ocular Drug Delivery Market Segmentation, By Country

Figure 3.           Europe Ocular Drug Delivery Market Overview

Figure 4.           Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5.           The UK to Show Significant Growth During Forecast Period

Figure 6.           Europe Ocular Drug Delivery Market, Industry Landscape

Figure 7.           Europe PEST Analysis

Figure 8.           Europe Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9.           Europe Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10.        Europe Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11.        Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Europe Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16.        Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Europe Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22.        Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        Europe Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30.        Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32.        Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33.        Europe: Ocular Drug Delivery Market Revenue Overview, by Country, 2021 (US$ MILLION)

Figure 34.        Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)

Figure 35.        Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36.        UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37.        France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38.        Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39.        Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40.        Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 41.        Impact of COVID-19 Pandemic in European Country Markets

  1. AbbVie Inc.                                              
  2. Bausch Health Companies Inc.            
  3. Novartis AG                                            
  4. Clearside Biomedical, Inc                      
  5. Alimera Sciences, Inc.                           
  6. GRAYBUG VISION, INC                      
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe ocular drug delivery market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in Europe ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription